PharmRep Direct

PharmRep Direct from the editors of Pharmaceutical Representative

October 15th , 2009 Issue 38 Vol. 11	www.pharmrep.com
Contact Editor: Reid Paul

Jury Sides with Family in Paxil Birth Defect Case
GSK is being ordered to pay $2.5 million in restitution to a Pennsylvania family. The firm was accused of not doing enough to warn consumers that taking the antidepressant Paxil, while pregnant, could lead to birth defects.
» MORE

Sandoz and Shire settle Adderal XR Dispute
Sandoz Shire Pharmaceuticals announced that it would allow Sandoz to market a generic version of its blockbuster ADHD med Adderal XR if it can clear FDA. But that’s a big if.
» MORE

Roche Reasses Genetech Pay
There will be smaller salaries, but more stock options in the future according to Severin Schwan, Roche’s chief executive.
» MORE

Diabetes: A State-by-State Breakdown
Among Americans 30 and older, 13.7 percent of men and 11.9 percent of women have diabetes. Almost one-third of them have never received a diagnosis of the disease.
» MORE

Action Amid Uncertainty: Preparing for Health Reform
As the health care reform debate continues to rage on Capitol Hill, pharma companies should be engaged in intense strategic planning for the future. Putting together a game plan now for the most likely reform scenarios will help companies to stay ahead of the curve.
» MORE

Biogeneric vs. Branded Drugs
When legislation allows the manufacture of biogenerics, who among manufacturers will win market share?
» MORE

The more people talk about healthcare reform the less consensus there is, what do you think of current efforts to reform the system?

H1N1 Vaccine Hits the Market

Pharma Takes Vermont to Court

PhRMA Backs Senate Reform Bill

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.